Aura Biosciences, Inc. (AURA)

Aura Biosciences, Inc. (AURA) is a healthcare company (biotechnology) based in the United States. The share price is $7.18, down 0.55% on the day, which values the company at $747.25M. Price as of 17 Nov 2026, 19:06 UTC, from Yahoo Finance.

Key facts

Share price
$7.18−0.55% today
Market value
$747.25M
200-week average
$7.899% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Aura Biosciences, Inc. in more detail

AURA trades at -3.5× next year's expected earnings. It sits 9% below its 200-week average of $7.89.

In its favour: More cash than debt. Worth checking: Weak Piotroski score; Share count keeps rising.

1 of the superinvestors tracked here hold AURA, including Peter Kolchinsky (0.2% of the portfolio).

Superinvestors holding AURA

1 of the investors tracked here report a position in their latest 13F filing.

Aura Biosciences, Inc. (AURA): questions and answers

What is Aura Biosciences, Inc.'s market cap?

Aura Biosciences, Inc. is valued at $747.25M at a share price of $7.18.

Is AURA above its 200-week moving average?

No. AURA is 9.0% below its 200-week average of $7.89. Long-term investors watch that line because strong companies rarely trade below it for long.

Does AURA pay a dividend?

Aura Biosciences, Inc. does not currently pay a regular dividend.

Which famous investors own AURA?

In their latest quarterly filings, Peter Kolchinsky (0.2% of the portfolio) hold AURA. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “Aura Biosciences, Inc. (AURA) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/AURA

Underlying data: Yahoo Finance; company filings with the SEC.